• By demonstrating a novel mechanism of regulation of FLN stability by ASB2a, our results point to FLNs and ASB2a as new players in DC biology.
Introduction
Cytoskeletal reorganization and response to mechanical stimuli are critical determinants of cell growth, stem-cell lineage switching, differentiation, or tissue morphogenesis and maintenance. 1 These depend on the coherence of the filamentous actin (F-actin) network. 2 In particular, actin-binding proteins are crucial in recruiting F-actin into 3-dimensional networks. Among them, filamin A (FLNa) mediates cross-linking of cytoplasmic actin into a dynamic structure resulting in an elastic network. [3] [4] [5] [6] In addition to organizing F-actin, FLNa participates in the anchoring of several transmembrane receptors including integrins to the actin cytoskeleton, providing mechanical stability to the cell membrane and cell-cell or cellextracellular matrix (ECM) connections. 7, 8 Integrins, but also FLNa, behave as mechanosensors that transduce forces and convert them into chemical responses. 9, 10 Furthermore, FLNa binds numerous signaling molecules and modulates their activity that, in turn, regulates actin assembly and disassembly. 7 Mammals have 3 highly conserved FLNs, FLNa, FLNb, and FLNc, that have a wide tissue expression, although FLNc is more restricted to striated muscles in adults. Mutations in any of the human FLNs are associated with a wide spectrum of developmental malformations and diseases. 7 All 3 FLNs are implicated in several aspects of cell shape and motility. Indeed, FLN concentration is a crucial determinant in the stiffness of the actin filament network, 11, 12 in cell spreading, [13] [14] [15] in cell adhesion, 15, 16 in cell migration, [17] [18] [19] and in invasion of cancer cells. 20, 21 In this context, deciphering the mechanisms controlling levels of FLN may have broad implications for our understanding of FLN functions in normal cells and dysfunctions in pathological contexts. FLN stability is regulated by proteolysis through cleavages by calpains 22 and ubiquitin-mediated proteasomal degradation controlled by the ASB2 E3 ubiquitin ligases. 13, 17, 23 Two ASB2 isoforms have been described: ASB2a and ASB2b that are involved in hematopoietic 13, 24 and myogenic 23 differentiation, respectively. Indeed, ASB2 proteins are the specificity subunits of cullin 5-ring E3 ubiquitin ligase complexes involved in the polyubiquitylation and subsequent degradation of specific substrates. 23, 25, 26 We have demonstrated previously that ASB2a triggers polyubiquitylation and drives proteasome-mediated degradation of all 3 FLNs. 13, 17, 27 Although ASB2a was originally identified as induced on retinoic acid differentiation of acute promyelocytic leukemia cells, 24, 28 several observations have suggested that ASB2 transcripts are also expressed in dendritic cells (DCs). [29] [30] [31] DCs play a central role in activation of primary immune responses. Immature DCs are located in nonlymphoid organs where they survey the microenvironment in search of antigens, including pathogens, foreign antigens, or self-antigens, or in the marginal zone of the spleen. On exposure to inflammatory stimuli, DCs of nonlymphoid organs initiate a tightly regulated maturation process that includes (i) a transient increase of macropinocytosis and phagocytosis 32 ; (ii) a transient decrease of cell motility 33 ; (iii) the accumulation of major histocompatibility complex (MHC)-II-peptide complexes at the cell surface 34 ; and (iv) a decrease of cell-ECM adhesion followed by a chemoattractive migration to the draining lymph nodes. 35 During these processes, DCs undergo profound changes in actin cytoskeleton.
Maturation is often triggered by the ligation of Toll-like receptors (TLRs) that initiate different signaling pathways in response to pathogen-associated molecular patterns. 36 Some TLRs such as TLR4, the receptor for lipopolysaccharide (LPS), are present at the plasma membrane, whereas others are in the endosomal compartment. Although the cell biology associated with DC maturation has been partly described, much remains to be learned about the molecular mechanisms controlling cytoskeletal rearrangements and adhesion and migration of immature DCs. Immature DCs harbor adhesion complexes known as podosomes that consist of a core of F-actin and actin-regulatory proteins surrounded by a ring of other proteins including integrins and talin. [37] [38] [39] Podosomes represent not only sites of attachment to the ECM but also sites of degradation of this matrix. 40 Here, we show that ASB2a is highly expressed in immature DCs and targets FLNa and FLNb to proteasomal degradation. Furthermore, using ASB2a knockout bone marrow-derived DCs (BMDCs), we investigate the role of ASB2a in immature DCs and show that ASB2a is essential to regulate cell spreading, podosome formation, ECM degradation, and migration.
Materials and methods

Animals
All mice were bred under specific pathogen-free conditions and were handled according to institutional guidelines under protocols approved by the Institut de (B) 59-CAGTGTCTGCTCTGAGGTCTCTC-39; and (C) 59-CTAGATAGCT CTACAGCTAATTCCG-39. Mx1-Cre mice were genotyped by PCR with primers 59-TCCCAACCTCAGTAGCAAGCCAAG-39 and 59-ACGACCGG-CAAACGGACAGAAGCA-39. To induce ASB2 knockout in adult animals, 300 mg poly(I·C) (Sigma) was injected 3 times at 2-day intervals to 6-to 8-week-old Mx1-Cre;ASB2 fl/fl and Mx1-Cre;ASB2 1/1 control mice. Mice were analyzed 6 weeks after the last injection to avoid adverse effects of poly(I·C).
Generation of BMDCs and spleen-derived DCs
To generate BMDCs, freshly dissected femurs and tibias were flushed with phosphate-buffered saline (PBS). Cells were spun for 5 minutes at 300 3 g and were cultured for 10 days in Iscove modified Dulbecco medium (IMDM) containing 10% fetal bovine serum (FBS; Biowest), granulocytemacrophage colony-stimulating factor-containing supernatant obtained from J558 cells, 1% L-glutamine, 1% penicillin-streptomycin, and 0.1% b-mercaptoethanol (Invitrogen). Spleen-derived DCs were obtained as described. 32 Briefly, sterile isolated spleen cells were recovered, and after red blood cell lysis, cells were spun for 5 minutes at 300 3 g and were cultured for 14 days in IMDM containing 10% FBS (Biowest), granulocytemacrophage colony-stimulating factor-containing supernatant obtained from J558 cells, 1% L-glutamine, 1% penicillin-streptomycin, 1 ng/mL of human transforming growth factor-b1, and 0.1% b-mercaptoethanol (Invitrogen). BMDCs were activated in IMDM containing 10% FBS, 1% L-glutamine, 1% penicillin-streptomycin, and 0.1% b-mercaptoethanol with 10 mg/mL of LPS (Sigma). The phenotype of DCs and their activation were analyzed by fluorescence-activated cell sorter (FACS).
Northern blots and quantitative reverse transcription (RT)-PCR
Total RNA was extracted using the NucleoSpin RNA II kit (Macherey-Nagel).
Northern blotting was performed as described. 42 The ASB2 probe corresponds to a region common to both ASB2 isoforms. Quantitative RT-PCR was performed as described. 23 Primers for the detection of mouse ASB2 mRNAs and mouse FLNa mRNA were designed based on chromosome sequences according to the requirements for real-time RT-PCR. Oligonucleotide primer sequences corresponding to distinct exons were as follows: forward 59-CACTCTGGCTCTGCACCTTC-39 and reverse 59-GGGCTCTGCAAGATTCTTCC-39 for ASB2a; forward 59-TTG TTGCCCAGACCT-39 and reverse 59-TCTCCTCCAGCTTCCAG-39 for ASB2b; forward 59-CACTTTACAAAGCCTGTGAG-39 and reverse 59-AGGATCTCCATGACCTCC-39 common to both ASB2 isoforms; forward 59-GCTATCGTGTCACCTATACC-39 and reverse 59-GAACC GTGGCAACTTTAGTC-39 for FLNa; forward 59-CGCGTCCTGGCAT TGTCTG-39 and reverse 59-GGCCTTGACCTTTTCAGTAAGTG-39 for Arbp.
In vivo expression and protein extracts
The pEGFP-C3-mASB2a and pEGFP-C3-mASB2aLA vectors expressing wild-type and the E3 ubiquitin ligase-defective mutant (mutation of leucine 547 to an alanine) of mouse ASB2a were constructed by standard procedures. NIH3T3 cells were grown in Dulbecco modified Eagle medium containing 4.5 g/L of glucose (Invitrogen), 10% FBS (PAA Laboratories), and penicillinstreptomycin. NIH3T3 cells were transfected using the Jet PEI reagent (Polyplus transfection) as recommended by the manufacturer. Cells were washed twice in PBS and were lysed in whole-cell extract buffer-containing 50 mM of Tris-HCl, pH 7.9, 150 mM of NaCl, 1 mM of EDTA, 0.1% Nonidet P-40, 10% glycerol, 1 mM of dithiothreitol, 1 mM of Na 3 VO 4 , 50 mM of NaF, 25 mM of b-glycerophosphate, 2 mM of sodium pyrophosphate, and 1% protease inhibitor cocktail (P8340; Sigma). After 2 freeze-thaw cycles in liquid nitrogen, the resulting cell lysates were cleared by a 10-minute 20 000 3 g centrifugation at 4°C. For personal use only. on April 3, 2017. by guest www.bloodjournal.org From Antibodies, immunofluorescence microscopy, and flow cytometry Anti-FLNb (N-16), anti-vinculin (h-VIN1), and anti-a-actinin-1 (clone AT6.172) were from Santa Cruz Biotechnology, Sigma, and Millipore, respectively. The anti-human FLNa antiserum that cross-reacts with mouse FLNa and used for western blot and immunofluorescence experiments has been described previously. 13 Immunoblot analyses and immunofluorescence microscopy studies were performed as described. 13, 16 Images were acquired using a Zeiss Axio Imager M2 with a 340/1.3 oil Ph3 or a 363/1.3 oil DIC Plan Apochromat objective (Zeiss). Images were acquired and processed using AxioVision software and an AxioCam MRm camera (Zeiss). F-actin was visualized with Alexa 633-phalloidin or Alexa 546-phalloidin (Invitrogen). Quantification of FLNa expression by FACS was performed as described. 26 For flow cytometry, APC-anti-CD11c, PE-anti-CD86 and PEanti-I-A[b] (Biolegend) were used. Samples were analyzed using a LSRII cytometer (Becton-Dickinson).
Cell spreading, gelatin-fluorescein isothiocyanate (FITC) degradation, and migration assay Gelatin-coated coverslips were prepared as described. 43 Immature BMDCs were harvested, washed in PBS, and rested in suspension in serum-free medium containing 0.2% bovine serum albumin for 1 hour at 37°C. Cells were then plated on glass coverslips coated with 50 mg/mL of fibronectin (BD Biosciences) for 30 minutes at 37°C or with 0.2 mg/mL of gelatin-FITC (BD Biosciences) for 6 hours at 37°C. Cells were then fixed with 4% paraformaldehyde, 15 mM of sucrose in PBS. Cell areas, degradation areas, and fluorescence intensities were measured using AxioVision software. For quantitative analyses, the total degradation areas of 50 image fields for each sample were calculated. Rested BMDCs were seeded on matrigel-coated transwell filters (6-well format, 8-mm pore size; BD Biosciences) at a density of 2.5 3 10 6 cells/well and were incubated at 37°C. Cells that had migrated after 16 hours to the bottom compartment were counted using trypan blue exclusion and were analyzed by immunofluorescence microscopy and by flow cytometry for CD11c expression.
Statistical analyses
P values were calculated with the Mann-Whitney t test.
Results
ASB2a expression in immature DCs correlates with loss of FLNa and FLNb
Although we and others have reported that ASB2a is expressed on induced maturation of myeloid leukemia cells, 24, 44, 45 microarray studies indicated that ASB2 is also expressed in human DCs purified from blood, 30 as well as in mouse classical DCs isolated from lymphoid or nonlymphoid tissues. 29, 31 We first evaluated the expression of ASB2 mRNAs in BMDCs. As shown in Figure 1A , ASB2 transcripts were highly expressed in immature DCs and, to a lesser extent, in the spleen and BM. By quantitative RT-PCR with primers specific to ASB2a, ASB2b, or with primers common to both isoforms, we demonstrated that only the ASB2a mRNAs were expressed in immature DCs ( Figure 1B) . Indeed, ASB2a transcripts were barely detected in BM cells and were progressively increased as cells differentiated into immature DCs in the presence of granulocyte macrophage-CSF ( Figure 1C) . Expression of ASB2a mRNAs were also observed in primary DCs derived from the spleen ( Figure 1D ). Interestingly, ASB2a expression was drastically downregulated during maturation stimulated by LPS ( Figure 1D ). This downregulation was also observed when DC maturation was triggered by other activating agents (data not shown). We demonstrated previously that the ASB2a protein targets all 3 FLNs for proteasomal degradation. 13, 17, 27 Therefore, we investigated the expression of the ubiquitously expressed FLNa and FLNb in DCs. Western blotting revealed that expression of FLNa and FLNb was increased after exposure of immature DCs to LPS (Figure 2A) . Expression of FLNa was also analyzed by immunofluorescence microscopy to visualize and quantify at the single-cell level the impact of LPS activation on FLNa expression ( Figure 2B) . Indeed, the median value of FLNa fluorescence intensities was increased in mature DCs compared with immature DCs. To further confirm these data, we determined the expression of FLNa by FACS analysis, which demonstrated that FLNa expression was higher in mature DCs than in immature DCs ( Figure 2C) . However, the abundance of FLNa mRNA in DCs was similar in immature DCs or in DCs cultured with LPS ( Figure 2D ). These findings are consistent with the downregulation of ASB2a on DC activation and suggest that the abundance of FLNa and FLNb is regulated by the ASB2a E3 ubiquitin ligase complex in DCs.
FLNa and FLNb are substrates of the ASB2a E3 ubiquitin ligase complex in immature DCs
To investigate ASB2 functions, we generated conditional genetargeted mice with exons 2 and 4 flanked by a pair of loxP sequences (Figure 3 DCs ( Figure 5D ), our results demonstrated that ASB2a regulates FLN abundance in immature DCs. As previously observed for the human ASB2a proteins, 13 the mouse ASB2a, but not the ASB2aLA E3 ubiquitin ligase-defective mutant, induced degradation of FLNa ( Figure 5E ). These results demonstrate that ASB2a targets FLNa and FLNb to proteasomal degradation in immature DCs.
ASB2a regulates spreading and adhesive structures in immature DCs
Critical to DC function in the initiation of an immune response is the ability to scan tissues in search of antigens. This mechanism involves morphologic changes and cell movement through the microenvironment. Through expression of exogenous ASB2a, we provided the first evidence that loss of FLNa and FLNb inhibited cell spreading on fibronectin. 13, 17 This finding led us to investigate the cell spreading of ASB2a 2/2 immature DCs to a fibronectin-coated surface. Indeed, the cell area of ASB2a
immature DCs allowed to spread onto fibronectin-coated coverslips was increased compared with that of ASB2a 1/1 immature DCs ( Figure 6A ). More precisely, the number of cells with a small area (,250 mm 2 ) was reduced in ASB2a 2/2 immature DCs ( Figure 6B ). These results demonstrate for the first time that ASB2a regulates cell spreading in physiological relevant settings. We next hypothesized that ASB2a might be an important regulator of adhesive structures such as podosomes in immature DCs. In adherent immature DCs generated from BM cells of control mice, podosomes can exist as individual puncta or as rosettes of podosomes ( Figure 6E ). As expected, the actin-rich core was surrounded by a region rich in vinculin in each discrete unit ( Figure 6E ). Furthermore, FLNa and vinculin were observed at individual podosomes ( Figure 6E) . Surprisingly, the percentage of cells with rosette podosomes was reduced in ASB2a
immature DCs ( Figure 6C,E) . This is in agreement with the fact that the percentage of cells with rosettes of podosomes is higher in FLNa-negative immature DCs than in FLNa-positive For We next investigated the capacity of ASB2a 2/2 immature DCs to degrade ECM in order to migrate through a dense tissue-matrix. The immature DCs were seeded on glass coverslips coated with fluorescent gelatin and were incubated for 6 hours before fixation and staining with antibodies to vinculin. As shown in Figure 7A , holes in the gelatin were observed in the vicinity of vinculincontaining podosomes of ASB2a 1/1 and ASB2a 2/2 immature DCs. However, ASB2a 2/2 immature DCs had a reduced ability to degrade the gelatin compared with ASB2a 1/1 immature DCs ( Figure 7A-B) . We then addressed whether the loss of ASB2a affects immature DC migration using a transwell migration assay coated with a dense layer of matrigel. Indeed, migration of ASB2a 2/2 immature DCs is reduced compared with that of ASB2a 1/1 immature DCs ( Figure 7C ).
Accordingly, migrated immature DCs from ASB2a 1/1 mice were mainly FLNa negative ( Figure 7D ). Thus, ASB2a regulates ECM degradation and subsequent migration of immature DCs.
Discussion
In this study, we uncovered new regulators of DC function: FLNs and their regulator ASB2a. By combining cell biology and biochemical studies with the generation and characterization of a loss-of-function mouse model, we demonstrated that FLNs are substrates of the ASB2a cullin 5-ring E3 ubiquitin ligase in DCs. Furthermore, we demonstrated that loss of ASB2a increased cell spreading and inhibited podosome rosette formation, ECM degradation, and immature DC migration through matrigel-coated filters.
We report here that ASB2a is expressed in mouse immature BM-and spleen-derived DCs. This trend is consistent with the high expression of ASB2 transcripts in mouse classical DCs isolated from lymphoid (CD8-positive and CD8-negative DCs) or nonlymphoid (CD103-positive DCs) tissues that has been reported recently. 31 Moreover, we showed that ASB2a is down-regulated after DC maturation. We further demonstrated that FLNa and FLNb are bona fide substrates of ASB2a E3 ubiquitin ligase activity in immature DCs and that ASB2a targets FLNa and FLNb to proteasomal degradation in immature DCs: (i) Decreased expression of FLNa and FLNb in immature DCs and increased expression in activated DCs are observed.
(ii) ASB2a-induced FLNa degradation is dependent on BMDCs assessed by quantitative real-time RT-PCR. Levels were normalized to Arbp. (E) Mouse ASB2a E3 ubiquitin ligase activity is required for FLNa degradation. NIH3T3 cells were transfected with GFP-mASB2a (ASB2a wt) or GFP-mASB2aLA (ASB2a mut) expression vectors and were analyzed 48 hours after transfection using an antibody directed against FLNa and phalloidin. Scale bar represents ***P , .001. [46] [47] [48] Although FLNs have been well studied in a variety of cell types and have been shown to play important roles in organizing cell shape and in regulating cell motility, 7 no previous studies have pointed to FLNs as regulators of DC biology. Indeed, it is established that the nonlinear elasticity of the F-actin network can be attributed to the flexibility of the cross-linker FLNs. 5, 6 In addition, the architecture of this network is dependent on actin and FLN concentrations, suggesting that FLN levels must be coordinated in time and space for proper actin-based cell motility. Our results here demonstrate an original regulation of the stability of FLNs by the ASB2a E3 ubiquitin ligase in physiological relevant settings. Although FLNs seem to compensate for each other, it is worth noting that ASB2a induces degradation of all 3 FLNs. 17 Therefore, our results are consistent with the fact that depletion of multiple FLNs in mouse embryonic fibroblasts showed defects in the spreading of the organelle-rich endoplasm. 15 Altogether, our work provides a mechanism through which FLN levels are regulated by proteasomal degradation in immature DCs, allowing fine-tuning modulation of cell spreading.
Podosomes are highly dynamic adhesive structures that represent sites of attachment to the ECM and sites of degradation of the matrix, allowing immature DC migration through tissues. 39, 40 Indeed, podosomes auto-assemble into rings called rosettes, characterized by their own dynamics that reflect the synergistic behavior of the individual units. 38, 49 That the percentage of cells with rosette podosomes was reduced in ASB2a 2/2 immature DCs indicates that ASB2a normally enhances the formation of rosette podosomes and/or stability in immature DCs. Furthermore, our results point to ASB2a as a critical regulator of ECM degradation and immature DC migration through matrigel-coated filters. Consistent with this finding, FLNa and FLNb suppress matrix degradation and invasion in HT1080 fibrosarcoma cells. 21 Conversely, in macrophages, FLNa stabilizes podosomes, thus enhancing matrix degradation, 19 indicating that the effect of FLNs on podosome formation and matrix degradation is cell type specific. Altogether, our data support the idea that, in immature DCs, ASB2a acts as a positive regulator of ECM invasion through degradation of FLNs.
More knowledge of the molecular mechanisms involved in DC circulation is needed to find ways to improve therapeutic strategies involving immunotherapy. In this context, FLNs and ASB2a as regulators of cell motility in immature DCs may represent novel therapeutic targets. In addition, low expression levels of FLNa correlate with breast cancer progression and downregulation of FLNa stimulates cancer cell migration, invasion, and metastatic formation. 20 Furthermore, it is worth noting that the FLNa/Refilin B complex controls the perinuclear actin network involved in nuclear shape reorganization during the epithelial-mesenchymal transition. 50 In this context, future investigation dedicated to the modulation of FLNa levels may also be relevant for anticancer therapies. 
